Browsing by Author Pedagogos, Eugenie

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2015Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialPerkovic, Vlado; Badve, Sunil; Cass, Alan; Clarke, Philip M; Coombes, Jeff; et al, Various; Ferrari, Paolo; McDonald, Stephen; Morrish, Alicia T; Pascoe, Elaine; Pedagogos, Eugenie; Zhang, Lei; The George Institute for Global HealthAssociation between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial, Canadian journal of kidney health and disease, vol.2, N/A, 2015,pp 1-10
2017Association between Serum Hepcidin-25 and Primary Resistance to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO TrialPerkovic, Vlado; Badve, Sunil V; Cass, Alan; Clarke, Philip; et al, Various; Gummer, Joel; McDonald, Stephen P; Morrish, Alicia T; Pascoe, Elaine M; Pedagogos, Eugenie; Trengove, Robert; The George Institute for Global HealthAssociation between Serum Hepcidin-25 and Primary Resistance to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial, Nephrology, vol.22, 7, 2017,pp 548-554
2011Barriers to Timely Arteriovenous Fistula Creation: A Study of Providers and PatientsCraig, Jonathan; Gallagher, Martin; Divi, Murthy; Gillies, Alastair; Gray, Nicholas; Lopez-Vargas, Pamela; McDonald, Stephen P; Pedagogos, Eugenie; Polkinghorne, Kevan R.; Russell, Christine; Snelling, Paul; Suranyi, Michael; Thein, Hla; Walker, Rowan G.; School of Public Health: Public Health; The George Institute for International HealthBarriers to Timely Arteriovenous Fistula Creation: A Study of Providers and Patients, American Journal of Kidney Diseases, vol.57, 6, 2011,pp 873-882
2016The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trialPerkovic, Vlado; Badve, Sunil; Cass, Alan; Clarke, Philip M; Coombes, Jeff; Dalziel, Kim; et al, Various; Ferrari, Paolo; McDonald, Stephen; Morrish, Alicia; Pascoe, Elaine; Pedagogos, Eugenie; Zhang, Lei; The George Institute for Global HealthThe effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial, Redox Report, vol.21, 1, 2016,pp 14-23
2008Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trialCass, Alan; Beller, Elaine; Fassett, Robert; Ferrari, Paolo; Hawley, Carmel; Johnson, David; MacDonald, Stephen; Pedagogos, Eugenie; Rosser, Brenda; Thompson, Charles; School of Public Health: MedicineOxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial, BMC Nephrology, vol.9, 8, 2008,pp 1-7
2012Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular riskPerkovic, Vlado; Badve, Sunil V.; Elder, Grahame; Hawley, Carmel; Pedagogos, Eugenie; Tan, Sven-Jean; Toussaint, Nigel; The George Institute for International HealthPhosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk, Nephrology, vol.17, 5, 2012,pp 433-444
2015A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) TrialPerkovic, Vlado; Badve, Sunil V.; Cass, Alan; Clarke, Philip M; Dalziel, Kim; et al, Various; Ferrari, Paolo; Johnson, David W; McDonald, S; Morrish, Alicia; Pascoe, Elaine; Pedagogos, Eugenie; The George Institute for Global HealthA Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial, American Journal of Kidney Diseases, vol.65, 1, 2015,pp 49-57